-
Dr. Vincent Hsu, an epidemiologist and AdventHealth’s infection control officer, discusses the vaccine, complications and why people should still keep getting vaccinated.
-
Government health officials are recommending a "pause" in vaccinations with the Johnson & Johnson COVID-19 vaccine. We're answering your questions as we learn more.
-
Gov. Ron DeSantis called the pause in administering the Johnson & Johnson vaccine a "speed bump," while acknowledging the state would follow the federal recommendation.
-
The Food and Drug Administration says Abbott's BinaxNOW test and Quidel's QuickVue can be sold without a prescription.
-
Updated study results say the vaccine is 76% effective against symptomatic COVID-19 and 100% effective against severe disease. Independent monitors had been concerned about a previous report.
-
NPR's Scott Simon asks FDA adviser Dr. Paul Offit about Johnson & Johnson's vaccine and other developments in the pandemic.
-
The FDA released an analysis of Johnson & Johnson's COVID-19 vaccine Wednesday morning that appears to support its authorization for emergency use.
-
The Food and Drug Administration is working on a playbook for how it could greenlight vaccine tweaks. Studies in hundreds of people, rather than tens of thousands, seem likely.
-
Agency officials said reducing the number of doses creates a potential for harm in patients because "they may assume that they are fully protected when they are not" and may "take unnecessary risks."
-
The FDA greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.